3D Systems Announces Appointment of The Honorable David J. Shulkin, MD to its Medical Advisory Board
ROCK HILL, S.C., June 07, 2022 (GLOBE NEWSWIRE) -- (NYSE:DDD) today announced the appointment of David J. Shulkin, MD, former United States Secretary of Veterans Affairs, to the company’s recently established Medical Advisory Board (MAB). The primary mission of the MAB is to provide strategic input, guidance, and recommendations for the company’s expanding efforts in regenerative medicine.
As one of the country’s most highly respected experts in health care management, Secretary Shulkin is widely recognized as a visionary leader for patient-centered care. His passion and expertise led to his early appointment as the first Chief Medical Officer for the University of Pennsylvania Health System, and later as President and CEO of Beth Israel Medical Center in New York.
As a testament to his leadership and vision, in 2015 Dr. Shulkin was appointed by President Barack Obama to serve as Undersecretary of Veterans Affairs for Health in the United States Department for Veterans Affairs (VA). Recognizing Dr. Shulkin’s leadership capabilities, in 2017 he was nominated by President Donald Trump to become the ninth United States Secretary of Veterans Affairs. He was confirmed by the Senate 100-0, becoming the most senior Government official to serve under both Presidents Obama and Trump. During his tenure, Secretary Shulkin worked to transform and modernize the VA healthcare system, the Government’s second-largest organization with over 350,000 employees and 1,700 facilities nationwide. Since leaving the VA, Secretary Shulkin has continued his distinguished career as a leading spokesman for patient-centered care and the continued transformation of health care to increase quality and accessibility to all in need. He is the author of three books, and the recipient of numerous career achievement awards, including his being named as one of the 100 Most Influential Leaders in Healthcare by Modern Healthcare.
Commenting on Dr. Shulkin’s appointment, Dr. Jeffrey Graves, president and CEO of 3D Systems stated, “We are extremely pleased with Secretary Shulkin’s willingness to join our newly formed Medical Advisory Board. His vast experience and expertise will be highly valuable in helping guide our efforts, not only in the rapidly emerging field of regenerative medicine but also as we continue to expand our existing Healthcare Solutions business, which is focused primarily on dental and orthopedic applications for 3D printing.”
In recognition of his appointment, Secretary Shulkin commented, “3D Systems is an acknowledged leader in the application of 3D printing technology to address some of the most challenging areas of medicine today. The ability their technology offers for mass customization of patient-specific solutions, ranging from orthopedic indications to the emerging field of regenerative medicine, is truly exceptional. I am honored and excited to be an advisor to the company as they continue to advance in all of these arenas.”
Forward-Looking Statements
Certain statements made in this release that are not statements of historical or current facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to be materially different from historical results or from any future results or projections expressed or implied by such forward-looking statements. In many cases, forward-looking statements can be identified by terms such as "believes," "belief," "expects," "may," "will," "estimates," "intends," "anticipates" or "plans" or the negative of these terms or other comparable terminology. Forward-looking statements are based upon management’s beliefs, assumptions, and current expectations and may include comments as to the company’s beliefs and expectations as to future events and trends affecting its business and are necessarily subject to uncertainties, many of which are outside the control of the company. The factors described under the headings "Forward-Looking Statements" and "Risk Factors" in the company’s periodic filings with the Securities and Exchange Commission, as well as other factors, could cause actual results to differ materially from those reflected or predicted in forward-looking statements. Although management believes that the expectations reflected in the forward-looking statements are reasonable, forward-looking statements are not, and should not be relied upon as a guarantee of future performance or results, nor will they necessarily prove to be accurate indications of the times at which such performance or results will be achieved. The forward-looking statements included are made only as of the date of the statement. 3D Systems undertakes no obligation to update or revise any forward-looking statements made by management or on its behalf, whether as a result of future developments, subsequent events or circumstances or otherwise, except as required by law.
About 3D Systems
More than 30 years ago, 3D Systems brought the innovation of 3D printing to the manufacturing industry. Today, as the leading additive manufacturing solutions partner, we bring innovation, performance, and reliability to every interaction - empowering our customers to create products and business models never before possible. Thanks to our unique offering of hardware, software, materials, and services, each application-specific solution is powered by the expertise of our application engineers who collaborate with customers to transform how they deliver their products and services. 3D Systems’ solutions address a variety of advanced applications in healthcare and industrial markets such as medical and dental, aerospace & defense, automotive, and durable goods. More information on the company is available at .
Investor Contact:
Media Contact:
